These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15758187)

  • 1. US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada.
    Eggertson L
    CMAJ; 2005 Mar; 172(7):865. PubMed ID: 15758187
    [No Abstract]   [Full Text] [Related]  

  • 2. Adderall XR: long acting stimulant for single daily dosing.
    Sallee FR; Smirnoff AV
    Expert Rev Neurother; 2004 Nov; 4(6):927-34. PubMed ID: 15853519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adderall and other drugs for attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1994 Nov; 36(936):109-10. PubMed ID: 7968783
    [No Abstract]   [Full Text] [Related]  

  • 4. Adderall and seizures.
    Thomas S; Upadhyaya H
    J Am Acad Child Adolesc Psychiatry; 2002 Apr; 41(4):365. PubMed ID: 11931590
    [No Abstract]   [Full Text] [Related]  

  • 5. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADHD drugs and cardiovascular risk.
    Nissen SE
    N Engl J Med; 2006 Apr; 354(14):1445-8. PubMed ID: 16549404
    [No Abstract]   [Full Text] [Related]  

  • 7. Adderall, the atypicals, and weight gain.
    Horrigan JP; Barnhill LJ; Kohli RR
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):620. PubMed ID: 11392337
    [No Abstract]   [Full Text] [Related]  

  • 8. Questions about Adderall XR.
    Biron P; Mintzes B; Lexchin J
    CMAJ; 2006 Apr; 174(9):1303-4. PubMed ID: 16636331
    [No Abstract]   [Full Text] [Related]  

  • 9. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.
    Faraone SV; Wigal SB; Hodgkins P
    J Atten Disord; 2007 Jul; 11(1):74-82. PubMed ID: 17606774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH; Donnelly C
    Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
    [No Abstract]   [Full Text] [Related]  

  • 11. [Attitude to questionable cadiac risks in stimulant administration].
    Fegert JM; Hebebrand J;
    Z Kinder Jugendpsychiatr Psychother; 2006 Jul; 34(4):295-7. PubMed ID: 16927572
    [No Abstract]   [Full Text] [Related]  

  • 12. To box OR NOT TO box.
    Newstadt M
    J Ky Med Assoc; 2006 Aug; 104(8):344-5. PubMed ID: 16939037
    [No Abstract]   [Full Text] [Related]  

  • 13. ADHD drugs and cardiovascular risk.
    Rappley MD; Moore JW; Dokken D
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729375
    [No Abstract]   [Full Text] [Related]  

  • 14. ECGs before stimulants in children.
    Med Lett Drugs Ther; 2008 Jul; 50(1291):60. PubMed ID: 18654112
    [No Abstract]   [Full Text] [Related]  

  • 15. Adderall-induced psychosis in an adolescent.
    Surles LK; May HJ; Garry JP
    J Am Board Fam Pract; 2002; 15(6):498-500. PubMed ID: 12463297
    [No Abstract]   [Full Text] [Related]  

  • 16. Debate over warnings for ADHD stimulants.
    Child Health Alert; 2006 Apr; 24():1. PubMed ID: 16673500
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN
    J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
    [No Abstract]   [Full Text] [Related]  

  • 18. Adderall in the land of Oz.
    Hammerschlag C
    Caring; 2013; 32(2):55. PubMed ID: 23697076
    [No Abstract]   [Full Text] [Related]  

  • 19. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
    Wigal SB; McGough JJ; McCracken JT; Biederman J; Spencer TJ; Posner KL; Wigal TL; Kollins SH; Clark TM; Mays DA; Zhang Y; Tulloch SJ
    J Atten Disord; 2005 Aug; 9(1):275-89. PubMed ID: 16371674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inconclusive evidence puts Adderall back on the market.
    Kondro W
    CMAJ; 2005 Oct; 173(8):858. PubMed ID: 16217102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.